Skip to content

A study of hydrogen peroxide for endoscopic management of pancreatic walled-off necrosis

Safety and efficacy of hydrogen peroxide lavage during endoscopic treatments for walled-off necrosis - Hydrogen peroxide for walled-off necrosis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000051227
Enrollment
10
Registered
2023-06-07
Start date
2023-04-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic walled-off necrosis (WON)

Interventions

Lavage using hydrogen peroxide during endoscopic interventions for WON

Sponsors

The University of Tokyo
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with WON according to the Revised Atlanta classification (Banks PA et al. Gut 2013;62:102-11) 2. Patients with symptoms associated with WON (e.g., fever, abdominal pain, abdominal distention, GI obstruction, obstructive jaundice) requiring endoscopic drainage

Exclusion criteria

Exclusion criteria: 1. Patients for whom endoscopic interventions are not suitable, including the following 1) Endoscopic or percutaneous approach to WON is not possible 2) Bleeding tendency (platelet count <50000/mm3 or PT-INR >1.5) 3) Antithrombotic agents cannot be discontinued according to the recommendations by the Japan Gastroenterological Endoscopy Society 4) Investigators consider that patients are not suitable for endoscopic or percutaneous treatment of WON 2. A history of severe allergic reactions (e.g., anaphylactic shock) to drugs 3. A history of an allergic reaction to hydrogen peroxide 4. Investigators consider that patients are not eligible for this study for any reasons

Design outcomes

Primary

MeasureTime frame
Moderate or severe adverse events during the index hospitalization

Secondary

MeasureTime frame
1. Clinical success (defined as a WON reduction in size with relief of symptoms) 2. Time to clinical success (treatment period) 3. Length of stay 4. All adverse events

Countries

Japan

Contacts

Public ContactTomotaka Saito

The University of Tokyo Hospital Department of Gastroenterology

tomsaito-gi@umin.ac.jp+81-3-3815-5411

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026